How weak will the job market get? That's one question that has been driving the shape of the $29 trillion Treasury market's ...

Stocks opened with small gains Monday, with the Nasdaq Composite attempting to build on Friday's record close and the S&P 500 ...

That’s true when you hire a financial planner. Even if you like and trust your adviser, there’s no way to know if you’re ...

An interesting nugget from the UBS Group's equity-strategy team notes touches on an important theme for investors to monitor.

A record-breaking stock market could be ready to hit the skids as investors may push the sell button after the Federal ...

Here are some of the stocks making notable moves in Monday's premarket action: Tesla's stock climbed nearly 6% after a filing ...

Analysts at Jefferies went looking for reasons to be cheerful about the U.S. outlook beyond their expectation for a ...

The latest round of U.S. and Chinese trade talks seemed to be going swimmingly until a tape bomb dropped that China found ...

BTIG and other strategists see a “sell the news” event for stocks this week — and a potential pullback for the S&P 500 not ...

My fiancée and I are getting married this spring. We are both 61 years old and financially secure, with enough savings to let ...

Have an issue with your financial adviser or looking for a new one? Email questions or concerns to [email protected].

Ocugen shares were 12% higher, at $1.20, after the company said it executed a licensing agreement with Kwangdong Pharmaceutical for the exclusive South Korean rights to OCU400. OCU400 is Ocugen's ...